Stock On Watch: ITI Inc’s Trend Up, Especially After Today’s Strong Session

Stock On Watch: ITI Inc's Trend Up, Especially After Today's Strong Session

The stock of ITI Inc (NASDAQ:ITCI) is a huge mover today! About 359,389 shares traded hands. ITI Inc (NASDAQ:ITCI) has declined 64.38% since April 4, 2016 and is downtrending. It has underperformed by 65.47% the S&P500.
The move comes after 8 months positive chart setup for the $452.35M company. It was reported on Nov, 4 by Barchart.com. We have $19.59 PT which if reached, will make NASDAQ:ITCI worth $325.69M more.

ITI Inc (NASDAQ:ITCI) Ratings Coverage

Out of 8 analysts covering Intra-Cellular Therapies (NASDAQ:ITCI), 6 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 75% are positive. Intra-Cellular Therapies has been the topic of 15 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The stock has “Outperform” rating given by RBC Capital Markets on Friday, November 6. On Wednesday, March 9 the stock rating was maintained by JMP Securities with “Market Outperform”. Piper Jaffray initiated the shares of ITCI in a report on Thursday, June 2 with “Overweight” rating. The stock of ITI Inc (NASDAQ:ITCI) has “Market Perform” rating given on Thursday, September 29 by JMP Securities. The stock of ITI Inc (NASDAQ:ITCI) earned “Sell” rating by Zacks on Friday, August 7. Guggenheim maintained ITI Inc (NASDAQ:ITCI) rating on Thursday, September 17. Guggenheim has “Buy” rating and $95 price target. SunTrust downgraded the stock to “Neutral” rating in Thursday, September 29 report.

According to Zacks Investment Research, “Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.”

Insitutional Activity: The institutional sentiment increased to 1.71 in Q2 2016. Its up 0.25, from 1.46 in 2016Q1. The ratio is positive, as 17 funds sold all ITI Inc shares owned while 28 reduced positions. 23 funds bought stakes while 54 increased positions. They now own 30.01 million shares or 2.84% more from 29.18 million shares in 2016Q1.
Ladenburg Thalmann Svcs has 0% invested in the company for 150 shares. Teacher Retirement Sys Of Texas last reported 0% of its portfolio in the stock. Gemmer Asset Management Ltd accumulated 5,000 shares or 0.1% of the stock. State Of New Jersey Common Pension Fund D, a New Jersey-based fund reported 62,500 shares. Cupps Capital Mngmt Ltd Liability Com, a Illinois-based fund reported 51,995 shares. Geode Mgmt Lc has 220,799 shares for 0% of their US portfolio. Blackrock Advisors Limited Liability Company, a Delaware-based fund reported 1.26M shares. Manufacturers Life Insur The, a Ontario – Canada-based fund reported 22,417 shares. Northern Corporation owns 392,471 shares or 0% of their US portfolio. The Maryland-based Rock Springs Cap L P has invested 0.55% in ITI Inc (NASDAQ:ITCI). Adage Cap Prtnrs Group Inc Limited Liability has 0.12% invested in the company for 1.10M shares. Quantitative Systematic Strategies Ltd Llc reported 22,102 shares or 0.39% of all its holdings. New York State Common Retirement Fund holds 0% of its portfolio in ITI Inc (NASDAQ:ITCI) for 29,451 shares. Vanguard Grp Inc Inc holds 0.01% of its portfolio in ITI Inc (NASDAQ:ITCI) for 2.36M shares. The Ohio-based Keybank Natl Association Oh has invested 0% in ITI Inc (NASDAQ:ITCI).

Another recent and important ITI Inc (NASDAQ:ITCI) news was published by Businesswire.com which published an article titled: “ITI and FAC Merge to Form KINEXO” on September 22, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment